Verition Fund Management
PAVM icon

Verition Fund Management’s PAVmed PAVM Stock Holding History

Verition Fund Management’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-313
Closed -$41.5K – 2600
2023
Q3 		$41.5K Hold
313
– – ﹤0.01% 2196
2023
Q2 		$57.5K Sell
313
-611
-66% -$122K ﹤0.01% 2027
2023
Q1 		$155K Buy
924
+611
+195% +$129K ﹤0.01% 1832
2022
Q4 		$67.7K Sell
313
-102
-25% -$38.5K ﹤0.01% 1873
2022
Q3 		$161K Hold
415
– – ﹤0.01% 2536
2022
Q2 		$175K Buy
415
+85
+26% +$41.1K ﹤0.01% 1983
2022
Q1 		$196K Buy
+330
New +$245K ﹤0.01% 2365
2021
Q2 		– Sell
-145
Closed -$289K – 2067
2021
Q1 		$289K Buy
+145
New +$218K ﹤0.01% 1146

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Verition Fund Management's PAVM Position: Q4 2023 in Review

Verition Fund Management sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 313 shares — an estimated $41.5K sold.

Verition Fund Management first reported a position in PAVM in Q1 2021 and held it in 8 quarters. The position peaked at $289K in Q1 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

  • Verition Fund Management reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
  • Verition Fund Management sold 313 PAVmed shares in Q4 2023, an estimated $41.5K.
  • Verition Fund Management first reported a position in PAVmed in Q1 2021 and held it in 8 quarters.
  • Verition Fund Management's PAVmed position peaked at $289K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Verition Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.